MedTech Spectrum

Article Name Predictive Diagnostics

Metropolis Healthcare launches advanced diagnostic lab in Kunnamkulam, Kerala

Extending high-quality testing services to patients with latest & innovative diagnostic technologies

17th July, 2023

Subang Jaya Medical Centre revolutionises healthcare in Malaysia by bringing hospital to homes

To drive further advancements in healthcare technology and foster transformative innovation in patient care

13th July, 2023

Surgery marketplace HD enters into partnership with Johnson & Johnson in Thailand

To enhance surgical skills of healthcare providers and widen patients’ access to innovative surgical procedures

13th July, 2023

eLovu Health Partners with Caduceus Medical Group for Comprehensive Maternal Health

eLovu Also Announces Integration with Brightside Health and Ruth Health

13th July, 2023

Germany-Saudi Arabian tie up of $30 M for data-driven multiomic testing

The joint venture will help enable the Saudi Vision 2030 and several other national priority initiatives related to genomic testing and the growth of the Saudi Arabian biotech sector

12th July, 2023

Germany-Saudi Arabian tie up of $30 M for data-driven multiomic testing

The joint venture will help enable the Saudi Vision 2030 and several other national priority initiatives related to genomic testing and the growth of the Saudi Arabian biotech sector

12th July, 2023

Hitachi collaborates with Mass General Brigham for R&D in regenerative medicine and GCT

Harnessing Hitachi's automated cell culturing and digital technology to overcome intractable diseases

11th July, 2023

DiamiR Biosciences Partners with JADBio to Utilize Machine Learning in Assay Development

DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that it has entered into an agreement with JADBio to utilize its Automated Machine Learning (AutoML) Platform and Services for development of predictive models based on DiamiR's microRNA panels and other factors for risk assessment in Alzheimer's disease and Rett syndrome.

10th July, 2023

“The interest of companies in biobanks has significantly increased but investments have not yet been realised”

BioBank Japan, a hospital-based multi-institutional biobank that has collected DNA, serum and medical record information from ~260,000 patients affected by one of 51 pre-defined diseases, is now launching a new phase to accelerate precision medicine and health in Japan. In an address on May 24 in Tokyo, Professor Yoichiro Kamatani, a member of the Steering Committee at BioBank Japan, presented the new phase and future direction of this important biobank for the future health of Japan. In an interaction with BioSpectrum Asia, Prof. Kamatani reveals more details about the work being done at BioBank Japan.

07th July, 2023

Alma, Sisram Medical's Acquisition of PhotonMed, Establishes Direct Operation in China

Alma, the world leader and innovator in providing energy-based medical and aesthetic solutions and a wholly-owned company by Sisram Medical (1696.HK), announced that it has completed the acquisition of PhotonMed International Ltd ("PhotonMed"), the leading Chinese distributor of energy-based devices, and is establishing a direct operation in mainland China.

04th July, 2023